Inhibikase Therapeutics said on Wednesday it would stop development of its experimental Parkinson's disease drug after it failed to improve patients' ability to carry out daily tasks such as eating ...

Researchers from the Cleveland Clinic Genome Center have successfully applied advanced artificial intelligence (AI) genetics ...

Advanced artificial intelligence genetics models have been successfully applied to Parkinson’s disease at CCGC.

Inhibikase Therapeutics, Inc. (IKT), a biopharmaceutical company with a market capitalization of $189.48 million, has announced the halting of further development of its Parkinson's disease drug, ...

Brain implants that could help repair the pathways damaged by Parkinson’s disease are being developed by University of ...

Bajaj Healthcare has received an approval from the Drug Controller General of India (DCGI) to manufacture both the API and Drug Formulation of Pimavanserin, a 34 mg capsule.

Scientists from the Institute of Nano Science and Technology (INST) Mohali, an autonomous institute of the Department of Science and Technology, announced a targeted ...

Researchers from the Cleveland Clinic Genome Center have successfully applied advanced artificial intelligence (AI) genetics ...

Bajaj Health has also extended the offer for Pimavanserin to several leading pharma companies to ensure availability in ...

PORTLAND, IA, UNITED STATES, January 30, 2025 /EINPresswire / -- Alarming rise in prevalence of cancer & infectious disease and increase in number of approval for exosome therapeutics & diagnostics ...

Earleen Fisher, an editor and writer whose career across five decades with The Associated Press gave her a front-row seat to ...